Fundraising FoxDimension Capital — Full Portfolio
29 tracked investments · listed companies and verified rows first
Monte Rosa develops molecular glue degrader (MGD) therapeutics using MGD chemistry, artificial intelligence, structural biology, and proteomics to target previously undruggable or inadequately drugged disease targets.
AI & Machine LearningBiotechDeep TechHealthtechBoston, US
Markus Warmuth(M.D., Chief Executive Officer)inSharon Townson(Ph.D., Chief Scientific Officer)inJohn Castle(Ph.D., Chief Data and Information Officer)inFilip Janku(M.D., Ph.D., Chief Medical Officer)inPhil Nickson(Ph.D., J.D., Chief Business and Legal Officer)inMagnus Walter(DPhil, Chief Technology Officer)in
Co-investorsAisling CapitalHBM PartnersNew Enterprise Associates (NEA)Versant VenturesAmzak HealthAvoro Capital Advisors+4 more
San Francisco, US
Todd Huffman(Founder)Megan Klimen(Founder)
BoardJoshua Wolfe(Director)Matt Ocko(Director)inAdam Goulborn(Director)
Board seatAdam Goulburn· per SEC Form D · $14M raise · filed Jul 2016
Co-investorsComet LabsDolby Family VenturesRecode VenturesDCVC (Data Collective)Lux CapitalOS Fund
Collaborative scholarly writing tool turned preprint archive, owned by Wiley since 2018.
New York, US
Nathan Jenkins(Founder)Alberto Pepe(Founder)Matteo Cantiello(Director)
BoardDavid Teten(Director)Brian Cohen(Director)
Board seatAdam Goulburn· per SEC Form D · $1.5M raise · filed Jan 2016
Co-investorsBloomberg BetaFf Venture CapitalNew York Venture PartnersKnight FoundationLux CapitalNew York Angels
Professional drone racing league whose pilots fly identical custom-built FPV drones on 3D courses broadcast worldwide.
New York, US
Nicholas Horbaczewski(Executive Officer, Director)
Board seatAdam Goulburn· per SEC Form D · $50M raise · filed Jun 2019
Co-investorsCerity Partners VenturesChaifetz GroupLerer HippeauLux CapitalRSE VenturesCourtside Ventures+2 more
Enveda operates a drug-discovery platform that analyzes natural samples—primarily plant-derived molecules—using mass spectrometry, AI foundation models, and automated high-throughput labs to identify their chemical structures and therapeutic properties.
AI & Machine LearningBiotechDeep TechBoulder, US
Viswa Colluru(Founder)inDaniel Wee(Executive Officer)Pieter Dorrestein(Founder)Viswa Colluru Pieter Dorrestein(Founder)
BoardRohit Sharma(Director)
Board seatZavain Dar· per SEC Form D
Co-investorsAir Street CapitalBoulder VenturesCatalio Capital Management, LPCox EnterprisesFPVHummingbird Ventures+20 more
Fiveonefour builds tooling focused on agent experience (AX), helping developers ship software that AI agents can use effectively.
AI & Machine LearningDeveloper ToolsSaaSPortland, US
Timote Gelinas Delisle(Executive Officer, Director, Promoter)Chris Crane(Founder)inNicolas Joseph(Founder)in
Board seatNan Li· per SEC Form D
Co-investorsFlybridge Capital PartnersMaterialized View CapitalVermilion Cliffs Ventures6 Dimensions CapitalRidge VenturesStage 2 Capital
NewLimit develops epigenetic reprogramming medicines to extend healthspan and treat age-related diseases at the intersection of computer science and biotechnology.
AI & Machine LearningBiotechLongevitySouth San Francisco, US
Brian Armstrong(Founder)inBlake Byers(Founder)inJacob Kimmel(Founder)inMichael Polansky(Executive Officer)
Board seatZavain Dar· per SEC Form D
Co-investorsS32Valor Equity Partners8VCAbstract Venturesage1Beyond Capital+15 more
Odyssey Therapeutics develops small molecule and protein therapeutics targeting upstream signaling nodes and innate immune system mechanisms to prevent pathological inflammation.
BiotechMedical DevicesCambridge, US
Gary D Glick(Executive Officer, Director)inGary D. Glick(Founder)
BoardJill Carroll(Director)inCarl Gordon(Director)inValerie Odegard(Director)Jeffrey Leiden(Director)
Board seatNan Li· per SEC Form D
Co-investorsActivant CapitalAscenta CapitalBalderton CapitalCatalio Capital Management, LPForesite CapitalGlobal BioAccess Fund+9 more
Pager Health provides a white-label care navigation platform that combines AI with clinicians to help members find, access, and stay engaged with healthcare.
AI & Machine LearningDigital HealthHealthtechNew York, US
Gaspard de Dreuzy(Executive Officer, Director)inPhillip Eytan(Executive Officer, Director)Oscar Salazar(Director)Philip Eytan(Executive Officer, Director, Promoter)Walter Jin(Chairman & CEO)inSandy Clarke(Chief Financial Officer)in
Board seatAdam Goulburn· per SEC Form D · $50M raise · filed Jun 2021
Co-investorsGV (Google Ventures)Health Catalyst CapitalNew Enterprise Associates (NEA)Streamlined VenturesThree Fields Capital Management LLCGoodwater Capital+2 more
Riskgaming creates immersive strategy simulation games where high-level decision-makers assume roles and navigate complex scenarios involving technology, business, and geopolitical challenges to explore alternative outcomes and inform real-world decisions.
BiotechHayward, US
Kegan Schouwenburg(Executive Officer, Director)Roger M. Perlmutter(Executive Officer, Director)in
BoardJoshua Wolfe(Director)inDror Berman(Director)James Tananbaum(Director)Leon Chen(Director)
Board seatAdam Goulburn· per SEC Form D · $525M raise · filed Jan 2022
Co-investorsBain Capital Life SciencesCisco InvestmentsForesite CapitalLux Capital
San Francisco, US
Shashank Samala(Founder)Jeffrey McAlvay(Executive Officer, Director)Jesse Koenig(Founder)Jeff McAlvay(Founder)
Board seatZavain Dar· per SEC Form D · $20.7M raise · filed Aug 2017
Co-investorsAlumni VenturesDolby Family VenturesGrit VenturesKeiretsu ForumLux CapitalPoint72 Ventures+5 more
Variant Bio is a therapeutics company that uses human genomics to guide drug development, drawing on expertise across genetics, molecular biology, therapeutics, anthropology, and ethics.
AI & Machine LearningBiotechDigital HealthNew York, US
Kaja Wasik(Founder)inAndrew Farnum(Founder)inStephane Castel(Founder)inCraig Basson(Chief Medical Officer, President of R&D)inHolly Vance(Chief Operating Officer)in
BoardJulie Sunderland(Director)
Board seatAdam Goulburn· per SEC Form D · $31.5M raise · filed Oct 2019
Co-investorsAlta PartnersGeneral CatalystLux CapitalSoftBank Vision Fund
.png)
Achira builds molecular world models that blend geometric deep learning, physics, and quantum chemistry to advance drug discovery and materials design.
AI & Machine LearningBiotechDeep Tech
John Chodera(Founder)inTheofanis Karaletsos(Founder)
BoardZavain Dar(Founder)in
Co-investorsCompoundNVIDIAAmplify PartnersDIMENSIONNVentures
AllStripes was a health technology company that built a research platform for rare diseases, collecting and de-identifying patients' medical records to power rare disease research.
Digital HealthHealthtech
Nancy Yu(Founder)inOnno Faber(Founder)
Co-investorsGaruda VenturesJAZZ Venture PartnersLux CapitalMaveronBond Capital ManagementCoinbase Ventures+9 more
Aspect Biosystems develops bioprinted tissue therapeutics using a platform that combines AI-powered bioprinting, computational design tools, therapeutic cells, and biomaterials to create implantable allogeneic tissues.
AI & Machine LearningBiotechLongevity
Tamer Mohamed(Founder)inSam Wadsworth(Founder)inSimon Beyer(Founder)inLeela Paris(Chief Technical Operations Officer)inMike Scott(Chief Development Officer)inRay Smith(Chief Financial Officer)in
Co-investorsAngel ForumCivilization Ventures Management, LlcInBC Investment Corp.JDRF T1D FundPage One VenturesPallasite Ventures+6 more
Automata provides lab automation and data management tools, enabling researchers and technicians to generate accurate data at scale through intuitive workflow creation.
Advanced ManufacturingAI & Machine LearningDeep TechHardwareHealthtechLegalTechRoboticsSaaSLondon, GB
Mostafa ElSayed(Founder)inSuryansh Chandra(Founder)Suryansh Chandra Mostafa ElSayed(Founder)
Co-investorsAir Street CapitalBlue Wire CapitalEntrepreneur FirstHCVCHummingbird VenturesIn-Q-Tel+12 more
Axi.om uses agentic intelligence and AI to predict, explain, and fix drug toxicity early in development by leveraging the largest experimental-to-clinical dataset of profiled molecules linked to human clinical outcomes.
AI & Machine LearningBiotechMedical Devices
Alex Beatson(Founder)Brandon White(Founder)
Co-investorsAbstract VenturesAmplify PartnersAtria VenturesCRV (Charles River Ventures)Inception Studio CapitalMana Ventures
Chai Discovery builds a computer-aided design suite using artificial intelligence to design new molecules and drugs.
AI & Machine LearningBiotechDeep TechSan Francisco, US
Joshua Meier(Founder)inJack Dent(Founder)inJacques Boitreaud(Founder)Jacques Boutreau(Founder)Joshua Meier Jack Dent(Founder)Matt McPartlon(Founder)
Co-investorsAmplify PartnersAvenir Growth CapitalavraBain Capital VenturesBattery VenturesDCVC (Data Collective)+30 more
Congruence is a drug discovery company that applies protein dynamics, biophysics, machine learning, and computational chemistry to model proteins in their full dynamic state and predict disease correction in silico.
AI & Machine LearningBiotechDeep Tech
Clarissa Desjardins(Founder)in
Co-investorsOrbiMedAlexandriaDIMENSIONAngelini VenturesBDC Thrive Venture Fund for WomenLumira Ventures+1 more
Convoke offers an AI platform that ingests and structures data from documents, scientific literature, SEC filings, and clinical data, and deploys custom agents to automate knowledge tasks and generate reports, manuscripts, and landscape analyses.
AI & Machine LearningBiotechEnterprise SoftwareHealthtechSaaS
Alex Telford(Founder)Maged Ahmed(Founder)Vikas Velagapudi(Founder)
Co-investorsAudaciousKleiner Perkins6 Dimensions CapitalACME CapitalComma CapitalLux Capital+2 more
Kaleidoscope provides a software platform for scientific R&D teams to track and communicate project data, manage complex research processes, and accelerate decision-making.
BiotechEnterprise SoftwareSaaSNew York City, US
Ewan Taylor(CSO and Co-founder)Geraldine Paulus(Co-founder, VP Operations)Brian Naughton(Co-founder and CTO)inDavid Yen(Founder)inBogdan Knezevic(Founder)in
Co-investorsAIN VenturesBurda Principal InvestmentsHAWKTAILHummingbird VenturesNorth Base Media3x5 Partners+1 more
Kimia is a therapeutics company developing new drugs through its ATLAS platform, working with partners in the pharmaceutical and biotechnology industries.
AI & Machine LearningBiotechDeep Tech
Stig Hansen(Founder)in
Co-investorsAirTree VenturesHorizons VenturesThe Column GroupBlackbird VenturesDIMENSIONSkip Capital
Lamin provides a lineage-native lakehouse platform for biological R&D that enables scientists to query, trace, and validate complex biological datasets across academia, biotech, and pharma.
AI & Machine LearningBiotechData & InfrastructureDeveloper ToolsEnterprise SoftwareHealthtechMunich, DE
Alex Wolf(CEO)inSunny Sun(Founder)inFrederic Enard(Co-CTO & Founding Engineer)inAlex T. Wolf(Founder)Ollie Baskeyfield(Recruiter)
Co-investorsPioneerY CombinatorNielsen Investments LPPillar VC
Modal provides a cloud platform that lets developers define compute, hardware, and application logic in Python and deploy to the cloud, with fast-booting containers and autoscaling GPUs.
AI & Machine LearningCloud ComputingDeveloper ToolsNew York, US
Erik Bernhardsson(Founder)inAkshat Bubna(Founder)inSeth Zelnick(Executive Officer)inAaron Krane(Founder)in
BoardPatrick Chase(Director)inSarah Catanzaro(Director)in
Co-investorsAmplify PartnersGeneral CatalystLux CapitalRedpoint VenturesCreandumAbstraction Capital+22 more
Stately Bio develops stem cell-derived regenerative and cell therapies using a machine learning platform that measures cell identity, behavior, and maturation directly from live-cell, label-free imaging.
AI & Machine LearningBiotechMedical Devices
Frank Li(Founder & CEO)Christian Elabd, PhD(Head of Biology)
Co-investorsAIX VenturesFoothill VenturesMitsui Global InvestmentAxial VCBoxOne VenturesCaffeinated Capital+1 more
Tamarind provides a computational platform for protein and molecular engineering, offering AI and physics-based tools to design antibodies, peptides, enzymes, and small molecules.
AI & Machine LearningBiotechDeep TechEnterprise SoftwareSaaSSan Francisco, US
Deniz Kavi(Founder)inSherry Liu(Founder)in
Co-investorsEight CapitalLynett Capital PartnersTranspose Platform ManagementTreeo VCY Combinator468 Capital+2 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
CareGuardianHometeam Technologies, Inc.Earendil Labs
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.